Max Robotics — Global Service Robot Directory + US Certification

About

Bart Kramer is a pioneering figure in tissue engineering and vascularized organoid biology, whose work bridges the critical gap between in vitro organ models and functional vascular networks. His most influential contribution, the 2022 paper “In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bed,” has garnered 108 citations and addresses a fundamental bottleneck in hepatic tissue modeling: the absence of perfusable vasculature. By developing a platform that enables routine grafting of liver spheroids and organoids onto a microfluidic vascular bed, Kramer has provided researchers with a powerful tool to study liver development, regeneration, and disease in a more physiologically relevant context. This innovation not only enhances the maturation and functionality of hepatic tissues but also opens new avenues for drug screening and personalized medicine. Kramer’s work is notable for its translational potential, offering a scalable method to integrate vascularization into organoid culture systems. His research continues to shape the future of tissue engineering, making him a key voice in the quest to build complex, vascularized human tissues in the lab.